The GLP is committed to full transparency. Download and review our Annual Report.

Monsanto ‘didn’t fully disclose’ involvement in 2016 glyphosate review, publisher says

Bayer AG’s defense of Roundup weed killer may take a hit after an academic journal [Critical Reviews in Toxicology] said Monsanto Co. didn’t fully disclose its involvement in published research finding the herbicide safe.

[T]he journal isn’t changing the papers’ scientific findings. But the journal’s publisher said [September 26] it’s issuing an “Expression of Concern”…. because the authors “have been unable to provide an adequate explanation to why the required level of transparency was not met on first submission.”

The correction stems from the journal’s requirement that any potential author conflicts must be disclosed. The initial disclosure statement indicated Monsanto’s involvement was limited to paying a consulting firm to develop the journal supplement entitled “An Independent Review of the Carcinogenic Potential of Glyphosate.” It declared that no Monsanto employees or attorneys reviewed manuscripts submitted to the journal.

Related article:  Congressional committee cuts funding to IARC over WHO agency's controversial glyphosate-cancer finding

Monsanto spokesman Sam Murphy wrote in an email that …. The company’s influence on the articles was “non-substantive,” such as providing formatting assistance and giving a history of regulatory overview, Murphy said. “The scientific conclusions are those of the authors and the authors alone.”

Read full, original article: Monsanto’s Role in Roundup Safety Study Is Corrected by Journal 

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend